CIK 0001386570
- Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262940963
- Phone
- +1 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-22 | BLOCK STEPHEN A Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2018-06-22 | Rubin Steven D Director | Grant or award · Stock Options (right to buy) | +20,000 | 20,000 | ||
| 2018-06-04 | Bratkovich Lisa CHIEF MARKETING OFFICER | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2018-05-18 | FARR KEVIN M CHIEF FINANCIAL OFFICER | Purchase | +5,000 | $3.83 | $19K | 5,000 |
| 2018-05-17 | Friedman Mark J GENERAL COUNSEL | Purchase | +3,000 | $3.60 | $11K | 3,000 |
| 2018-05-16 | Jaksch Frank L Jr CEO | Purchase | +4,300 | $3.56 | $15K | 211,357 |
| 2018-05-15 | Jaksch Frank L Jr CEO | Purchase | +5,500 | $3.61 | $20K | 207,057 |
| 2018-05-15 | Fried Robert N PRESIDENT, COO | Purchase | +10,000 | $3.63 | $36K | 926,574 |
| 2018-05-15 | Fried Robert N PRESIDENT, COO | Grant or award | +10,000 | $3.63 | $36K | 926,574 |
| 2018-03-29 | Jaksch Frank L Jr CEO | Exercise or conversion | +474 | $4.50 | $2K | 202,031 |
| 2018-03-29 | Jaksch Frank L Jr CEO | Sale | −474 | $4.60 | $2K | 201,557 |
| 2018-03-29 | Jaksch Frank L Jr CEO | Exercise or conversion · Employee Stock Options (right to buy) | −474 | 171,503 | ||
| 2018-03-27 | Jaksch Frank L Jr CEO | Exercise or conversion | +24,578 | $4.50 | $111K | 226,135 |
| 2018-03-27 | Jaksch Frank L Jr CEO | Sale | −24,578 | $4.60 | $113K | 201,557 |
| 2018-03-27 | Jaksch Frank L Jr CEO | Exercise or conversion · Employee Stock Options (right to buy) | −24,578 | 171,977 | ||
| 2018-01-22 | Friedman Mark J General Counsel | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2018-01-21 | Rhonemus Troy Allen EXECUTIVE VICE PRESIDENT | Grant or award · Employee Stock Options (right to buy) | +120,000 | 120,000 | ||
| 2018-01-21 | Fried Robert N PRESIDENT, COO, CSO | Grant or award · Employee Stock Options (right to buy) | +300,000 | 300,000 | ||
| 2018-01-21 | Jaksch Frank L Jr CEO | Grant or award · Employee Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2018-01-11 | Jaksch Frank L Jr CEO | Exercise or conversion | +6,249 | $4.50 | $28K | 207,806 |
Page 9 of 12 · 238 trades